About KGH Advisors
Kate Gallin Heffernan, JD, has over ten years of experience advising the health care industry on issues related to human subjects research, research compliance and misconduct, and other discrete specialty areas.
Prior to founding KGH Advisors, Kate practiced in the health care group of Ropes & Gray LLP for several years, after which she worked in the Research and Technology division of the Office of the General Counsel at Partners HealthCare System, which encompasses Massachusetts General Hospital and Brigham and Women's Hospital, among others.
Kate received her BA from Georgetown University (magna cum laude, Phi Beta Kappa) and her JD from New York University School of Law (magna cum laude, Order of the Coif). Following law school, Kate clerked for the Honorable Dennis Jacobs on the United States Court of Appeals for the Second Circuit. In June 2009, Kate completed a fellowship in medical ethics at Harvard Medical School, Division of Medical Ethics.
Kate is involved with policy and thought development on the national and international scene, for example serving as Associate Director of the Multi-Regional Clinical Trials Initiative from September 2009-January 2010, an interdisciplinary group of providers and representatives from the pharmaceutical industry convened to provide recommendations on challenging ethical issues in international research.
Kate has spoken and published on many issues related to human subjects research and human embryonic stem cell research, and her writings have appeared in, among others, Cell Stem Cell, The Hastings Center publication IRB: Ethics and Human Research, and BNA Medical Research Law & Policy Report, of which she is a member of the Editoral Advisory Board. See the News & Publications section for additional information and copies of relevant publications.